PeptideDB

AGN-201904Z

CAS: 651728-41-5 F: C25H24N3NaO8S2 W: 581.59

AGN-201904Z is a compound that inhibits gastric acid secretion and is a new type of proton pump inhibitor that can produ
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity AGN-201904Z is a compound that inhibits gastric acid secretion and is a new type of proton pump inhibitor that can produce more significant and lasting acid suppression effects than esomeprazole.
CAS 651728-41-5
Formula C25H24N3NaO8S2
Molar Mass 581.59
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z